RÉSUMÉ
The relationship between Helicobacter pylori infection and gallbladder diseases, particularly cholecystitis and gallbladder polyps, remains unclear. This study aimed to investigate the presence of H. pylori in gallbladder tissues and its potential role in gallbladder pathologies, as well as to examine the expression of chemokines CXCL2 and CXCL5 in these conditions. MATERIAL AND METHODS: A total of 137 laparoscopically excised gallbladders were analysed through histological examination, PCR for H. pylori-specific DNA, and quantitative real-time PCR for CXCL2 and CXCL5 gene expression. The study cohort included patients with acute calculous cholecystitis, chronic calculous cholecystitis, and gallbladder polyps. RESULTS: H. pylori was detected in 30.7% of cases by histological methods and 42.3% by PCR. Elevated expression of CXCL2 and CXCL5 was observed in 62% and 57.7% of cases, respectively, with a higher prevalence in acute cholecystitis compared to chronic conditions. However, no statistically significant association was found between H. pylori presence and the forms of cholecystitis, as well as between H. pylori presence and chemokine expression in gallbladder. CONCLUSIONS: The study did not establish a direct link between the presence of H. pylori infection and forms of gallbladder pathologies. The findings suggest that other factors other than H. pylori may contribute to the upregulation of CXCL2 and CXCL5 in gallbladder diseases. Further research is needed to elucidate the complex interactions between H. pylori, chemokines, and gallbladder pathologies.
Sujet(s)
Chimiokine CXCL2 , Chimiokine CXCL5 , Vésicule biliaire , Infections à Helicobacter , Helicobacter pylori , Humains , Helicobacter pylori/isolement et purification , Helicobacter pylori/pathogénicité , Infections à Helicobacter/microbiologie , Infections à Helicobacter/anatomopathologie , Infections à Helicobacter/complications , Infections à Helicobacter/génétique , Mâle , Vésicule biliaire/microbiologie , Vésicule biliaire/anatomopathologie , Vésicule biliaire/chirurgie , Femelle , Adulte d'âge moyen , Chimiokine CXCL5/génétique , Chimiokine CXCL5/métabolisme , Chimiokine CXCL2/génétique , Chimiokine CXCL2/métabolisme , Adulte , Cholécystite/microbiologie , Cholécystite/anatomopathologie , Cholécystite/chirurgie , Polypes/microbiologie , Polypes/anatomopathologie , Maladies de la vésicule biliaire/microbiologie , Maladies de la vésicule biliaire/anatomopathologie , Maladies de la vésicule biliaire/chirurgie , Sujet âgéRÉSUMÉ
BACKGROUND: The natural history of symptomatic uncomplicated gallstone disease is largely unknown. We examined the risk of progressing from symptomatic uncomplicated to complicated gallstone disease in a large regional cohort of patients, where disruptions in elective surgical capacities have led to the indefinite postponement of surgery for benign conditions, including cholecystectomies. METHODS: Patients with radiologically diagnosed incident symptomatic and uncomplicated gallstone disease were identified from outpatient clinics and emergency departments on the Island of Funen, Denmark. The absolute risk of complications (cholecystitis, cholangitis, pancreatitis, acute cholecystectomy for unremitting pain) was calculated using death and elective cholecystectomies as competing risks using the Aalen-Johansen method. Cox proportional hazards regression analysis was used to estimate hazard ratios (HRs) of gallstone complications associated with patient and gallstone characteristics. RESULTS: Two hundred eighty-six patients diagnosed with incident symptomatic, uncomplicated gallstone disease from 1 January 2020 to 1 July 2023 were identified. During 79,170 person-years of observation, 176 (61.5%) patients developed a gallstone-related complication. The 6-, 12- and 24-month risk of developing gallstone-related complications were 36%, 55% and 81%. The risk of developing complications related to common bile duct stones was lowest with larger stones (aHR per millimeter increase = 0.89 (0.82-0.97), p < 0.01), while no covariates were statistically significantly associated with the risk of cholecystitis. Eighty-five (30%) patients underwent elective laparoscopic cholecystectomy, with one patient (1.2%) developing a gallstone-related complication afterward. CONCLUSIONS: The risk of developing complications to symptomatic gallstones in a general Scandinavian population is high, and prophylactic cholecystectomy should be considered.
Sujet(s)
Cholécystectomie , Calculs biliaires , Humains , Femelle , Mâle , Calculs biliaires/complications , Calculs biliaires/chirurgie , Adulte d'âge moyen , Danemark/épidémiologie , Sujet âgé , Cholécystectomie/effets indésirables , Adulte , Facteurs de risque , Pancréatite/étiologie , Modèles des risques proportionnels , Angiocholite/étiologie , Cholécystite/étiologie , Cholécystite/chirurgie , Cholécystite/complications , Études de cohortes , Sujet âgé de 80 ans ou plus , Interventions chirurgicales non urgentes/effets indésirables , Évolution de la maladieRÉSUMÉ
ABSTRACT: Gallbladder torsion is a rare cause of acute surgical abdomen. Early recognition and surgical intervention are important for reducing complications and improving postoperative patient outcomes, but standard imaging and laboratory evaluation typically are indistinguishable from those of acute cholecystitis. This article describes a patient with gangrenous cholecystitis secondary to torsion and summarizes recommendations for evaluation and management.
Sujet(s)
Maladies de la vésicule biliaire , Gangrène , Anomalie de torsion , Humains , Anomalie de torsion/chirurgie , Anomalie de torsion/diagnostic , Maladies de la vésicule biliaire/chirurgie , Maladies de la vésicule biliaire/diagnostic , Gangrène/étiologie , Gangrène/chirurgie , Vésicule biliaire/chirurgie , Vésicule biliaire/imagerie diagnostique , Femelle , Cholécystite/chirurgie , Cholécystite/diagnostic , Cholécystite/étiologie , Mâle , Abdomen aigu/étiologie , TomodensitométrieRÉSUMÉ
Biliary dysbiosis is associated with gallbladder cancer (GBC). We aimed to look for biliary bacteria specifically detected in GBC patients. We used 16S rRNA-based metagenomic analysis to elucidate biliary microbiota in 30 GBC and 30 gallstones-associated chronic cholecystitis patients. Relative abundance of five genera, Streptococcus, Enterococcus, Halomonas, Escherichia and Caulobacter was significantly associated with GBC. Of 15-species, 7 were detected significantly higher in GBC, Streptococcus anginosus, Streptococcus constellatus, Streptococcus intermedius, Actinomyces bowdenii, Actinomyces israelii, Actinomyces gerencseriae, and Escherichia fergusonii were biosafety level-2 infectious bacteria; other 8 species were biosafety level-1 bacteria. These bacterial species may be involved in pathogenesis of GBC.
Sujet(s)
Cholécystite , Tumeurs de la vésicule biliaire , Calculs biliaires , Métagénomique , Humains , Tumeurs de la vésicule biliaire/microbiologie , Cholécystite/microbiologie , Calculs biliaires/microbiologie , Femelle , Mâle , Métagénomique/méthodes , Adulte d'âge moyen , Sujet âgé , ARN ribosomique 16S/génétique , Maladie chronique , Bactéries/génétique , Bactéries/classification , Bactéries/isolement et purification , Microbiote , Adulte , Dysbiose/microbiologieRÉSUMÉ
BACKGROUND: Robotic surgery has gained widespread acceptance in elective interventions, yet its role in emergency procedures remains underexplored. While the 2021 WSES position paper discussed limited studies on the application of robotics in emergency general surgery, it recommended strict patient selection, adequate training, and improved platform accessibility. This prospective study aims to define the role of robotic surgery in emergency settings, evaluating intraoperative and postoperative outcomes and assessing its feasibility and safety. METHODS: The ROEM study is an observational, prospective, multicentre, international analysis of clinically stable adult patients undergoing robotic surgery for emergency treatment of acute pathologies including diverticulitis, cholecystitis, and obstructed hernias. Data collection includes patient demographics and intervention details. Furthermore, data relating to the operating theatre team and the surgical instruments used will be collected in order to conduct a cost analysis. The study plans to enrol at least 500 patients from 50 participating centres, with each centre having a local lead and collaborators. All data will be collected and stored online through a secure server running the Research Electronic Data Capture (REDCap) web application. Ethical considerations and data governance will be paramount, requiring local ethical committee approvals from participating centres. DISCUSSION: Current literature and expert consensus suggest the feasibility of robotic surgery in emergencies with proper support. However, challenges include staff training, scheduling conflicts with elective surgeries, and increased costs. The ROEM study seeks to contribute valuable data on the safety, feasibility, and cost-effectiveness of robotic surgery in emergency settings, focusing on specific pathologies. Previous studies on cholecystitis, abdominal hernias, and diverticulitis provide insights into the benefits and challenges of robotic approaches. It is necessary to identify patient populations that benefit most from robotic emergency surgery to optimize outcomes and justify costs.
Sujet(s)
Interventions chirurgicales robotisées , Humains , Interventions chirurgicales robotisées/méthodes , Études prospectives , Urgences , Études observationnelles comme sujet , Cholécystite/chirurgie , Diverticulite/chirurgieRÉSUMÉ
BACKGROUND: With the outbreak of the COVID-19 pandemic medical care focused on management of the infectious event. Elective interventions were cancelled and the general advice was to stay at home. How this impacted urgent and elective cholecystectomies is the subject of this work. METHOD: Urgent and elective cholecystectomy patients during the first year of the pandemic were compared with those of the previous year. The primary endpoint was the frequency of surgery. Furthermore, the American Society of Anesthesiologists (ASA) score, symptom duration until presentation as well as until surgery, preoperative inflammatory parameters, imaging, positive Murphy's sign, type and duration of surgery, intraoperative drain placement, intraoperative and histological severity, need for and duration of postoperative antibiotic therapy, intensive care stay, length of stay and occurrence of postoperative complications were recorded. RESULTS: During the pandemic patients were sicker (ASA 2.13 vs. 2.31; pâ¯= 0.039), the operating time was prolonged (64.4â¯min vs. 74.9â¯min; pâ¯= 0.001) and patients were more likely to have concomitant peritonitis (15.4% vs. 29.1%: pâ¯= 0.007). Furthermore, there was a trend in the presence of leukocytosis, a positive Murphy's sign, intraoperative drain placement, intraoperative severity of inflammation, duration of postoperative antibiotic therapy and complication rate. CONCLUSION: During the COVID-19 pandemic cholecystitis presented with more pronounced inflammation, the surgical conditions were more difficult and postoperative recovery was prolonged.
Sujet(s)
COVID-19 , Cholécystectomie , Interventions chirurgicales non urgentes , Pandémies , Humains , COVID-19/épidémiologie , Femelle , Mâle , Études rétrospectives , Adulte d'âge moyen , Sujet âgé , Cholécystite/chirurgie , Cholécystite/épidémiologie , Adulte , Résultat thérapeutique , Études de cohortes , Complications postopératoires/épidémiologie , Indice de gravité de la maladie , Sujet âgé de 80 ans ou plus , Allemagne/épidémiologie , SARS-CoV-2 , Durée du séjour , UrgencesRÉSUMÉ
OBJECTIVE: Elucidating complex ecosystems and molecular features of gallbladder cancer (GBC) and benign gallbladder diseases is pivotal to proactive cancer prevention and optimal therapeutic intervention. DESIGN: We performed single-cell transcriptome analysis on 230 737 cells from 15 GBCs, 4 cholecystitis samples, 3 gallbladder polyps, 5 gallbladder adenomas and 16 adjacent normal tissues. Findings were validated through large-scale histological assays, digital spatial profiler multiplexed immunofluorescence (GeoMx), etc. Further molecular mechanism was demonstrated with in vitro and in vivo studies. RESULTS: The cell atlas unveiled an altered immune landscape across different pathological states of gallbladder diseases. GBC featured a more suppressive immune microenvironment with distinct T-cell proliferation patterns and macrophage attributions in different GBC subtypes. Notably, mutual exclusivity between stromal and immune cells was identified and remarkable stromal ecosystem (SC) heterogeneity during GBC progression was unveiled. Specifically, SC1 demonstrated active interaction between Fibro-iCAF and Endo-Tip cells, correlating with poor prognosis. Moreover, epithelium genetic variations within adenocarcinoma (AC) indicated an evolutionary similarity between adenoma and AC. Importantly, our study identified elevated olfactomedin 4 (OLFM4) in epithelial cells as a central player in GBC progression. OLFM4 was related to T-cell malfunction and tumour-associated macrophage infiltration, leading to a worse prognosis in GBC. Further investigations revealed that OLFM4 upregulated programmed death-ligand 1 (PD-L1) expression through the MAPK-AP1 axis, facilitating tumour cell immune evasion. CONCLUSION: These findings offer a valuable resource for understanding the pathogenesis of gallbladder diseases and indicate OLFM4 as a potential biomarker and therapeutic target for GBC.
Sujet(s)
Tumeurs de la vésicule biliaire , Analyse sur cellule unique , Microenvironnement tumoral , Tumeurs de la vésicule biliaire/anatomopathologie , Tumeurs de la vésicule biliaire/immunologie , Tumeurs de la vésicule biliaire/génétique , Tumeurs de la vésicule biliaire/métabolisme , Humains , Microenvironnement tumoral/immunologie , Adénomes/anatomopathologie , Adénomes/génétique , Adénomes/immunologie , Adénomes/métabolisme , Adénocarcinome/anatomopathologie , Adénocarcinome/génétique , Adénocarcinome/immunologie , Mâle , Macrophages/immunologie , Macrophages/métabolisme , Antigène CD274/métabolisme , Antigène CD274/génétique , Cholécystite/anatomopathologie , Cholécystite/métabolisme , Analyse de profil d'expression de gènes/méthodes , Polypes/anatomopathologie , Polypes/génétique , Polypes/immunologie , Facteur de stimulation des colonies de granulocytesRÉSUMÉ
A focused point-of-care abdominal ultrasound is an examination performed at the patient's location and interpreted within the clinical context. This review gives an overview of this examination modality. The objective is to rapidly address predefined dichotomised questions about the presence of an abdominal aortic aneurysm, gallstones, cholecystitis, hydronephrosis, urinary retention, free intraperitoneal fluid, and small bowel obstruction. FAUS is a valuable tool for emergency physicians to promptly confirm various conditions upon the patients' arrival, thus reducing the time to diagnosis and in some cases eliminating the need for other imaging.
Sujet(s)
Anévrysme de l'aorte abdominale , Hydronéphrose , Échographie , Humains , Échographie/méthodes , Anévrysme de l'aorte abdominale/imagerie diagnostique , Hydronéphrose/imagerie diagnostique , Abdomen/imagerie diagnostique , Calculs biliaires/imagerie diagnostique , Cholécystite/imagerie diagnostique , Occlusion intestinale/imagerie diagnostique , Rétention d'urine/imagerie diagnostique , Rétention d'urine/étiologie , Systèmes automatisés lit maladeRÉSUMÉ
BACKGROUND The gallbladder develops from the hepatic diverticulum during the fourth week of gestation, which also give rise to the liver, extrahepatic biliary ducts, and ventral part of the pancreas. Infrequently, the gallbladder has malformation or disruption in embryogenesis, leading to congenital anomalies. There are various congenital anomalies that can arise in the gallbladder. True or congenital diverticulum of the gallbladder is a rare entity that accounts for only 0.06% of gallbladder congenital anomalies and 0.0008% of cholecystectomies at the Mayo Clinic. CASE REPORT Herein, we report a rare case of a 38-year-old woman who presented to Jubail General Hospital's surgery clinic with right upper-quadrant (RUQ) pain associated with vomiting after meals for 1 month. Laparoscopic cholecystectomy was done and gallbladder tissue was sent to histopathology. Gross examination revealed an outpouching mucosa within the wall that was proven to consist of muscularis and serosa layers under light microscope. Interestingly, xanthogranulomatous inflammation was confined to the diverticulum, unlike the chronic inflammation involving the remaining gallbladder. Based on the above findings, the diagnosis of congenital diverticulum with xanthogranulomatous cholecystitis was made. CONCLUSIONS Gallbladders associated with a true diverticulum are uncommonly found to be buried in the liver, leading to surgical difficulties during cholecystectomy. Therefore, background knowledge of occasional anomalies plays a crucial role in guiding the surgeon to choose the optimal method of management. We also discuss the associated complications that accompany these anomalies, such as non-specific prolonged ailments, acalculous cholecystitis, cholecystitis and cholelithiasis, recurrent cholangitis, and carcinoma of the gallbladder.
Sujet(s)
Cholécystite , Diverticule , Vésicule biliaire , Xanthomatose , Humains , Femelle , Adulte , Xanthomatose/chirurgie , Xanthomatose/diagnostic , Cholécystite/chirurgie , Cholécystite/diagnostic , Diverticule/chirurgie , Diverticule/diagnostic , Diverticule/complications , Vésicule biliaire/malformations , Vésicule biliaire/anatomopathologie , Granulome/chirurgie , Granulome/diagnostic , Cholécystectomie laparoscopiqueRÉSUMÉ
BACKGROUND: The aim of this study was to establish features of inflammation in histologically normal gallbladders with gallstones and compare the expression of inflammatory markers in acutely and chronically inflamed gallbladders. METHODS: Immunohistochemistry was performed on formalin-fixed paraffin-embedded gallbladders for tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-2R, and substance p in three groups: Group I (n = 60) chronic cholecystitis, Group II (n = 57) acute cholecystitis and Group III (n = 45) histologically normal gallbladders with gallstones. Expression was quantified using the H-scoring system. RESULTS: Median, interquartile range expression of mucosal IL-2R in Groups I (2.65, 0.87-7.97) and II (12.30, 6.15-25.55) was significantly increased compared with group III (0.40, 0.10-1.35, p < 0.05). Submucosal IL-2R expression in Groups I (2.0, 1.12-4.95) and II (10.0, 5.95-14.30) was also significantly increased compared with Group III (0.50, 0.15-1.05, p < 0.05). There was no difference in the lymphoid cell IL-6 expression between Groups I (5.95, 1.60-18.15), II (6.10, 1.1-36.15) and III (8.30, 2.60-26.35, p > 0.05). Epithelial IL-6 expression of Group III (8.3, 2.6-26.3) was significantly increased compared with group I (0.5, 0-10.2, p < 0.05) as was epithelial TNF-α expression in Group III (85.0, 70.50-92.0) compared with Groups I (72.50, 45.25.0-85.50, p < 0.05) and II (61.0, 30.0-92.0, p < 0.05). Lymphoid cell Substance P expression in Groups I (1.90, 1.32-2.65) and II (5.62, 2.50-20.8) was significantly increased compared with Group III (1.0,1.0-1.30, p < 0.05). Epithelial cell expression of Substance P in Group III (121.7, 94.6-167.8) was significantly increased compared with Groups I (75.7, 50.6-105.3, p < 0.05) and II (78.9, 43.5-118.5, p < 0.05). CONCLUSION: Histologically normal gallbladders with gallstones exhibited features of inflammation on immunohistochemistry.
Sujet(s)
Calculs biliaires , Immunohistochimie , Humains , Calculs biliaires/anatomopathologie , Calculs biliaires/métabolisme , Mâle , Femelle , Adulte d'âge moyen , Adulte , Interleukine-6/métabolisme , Facteur de nécrose tumorale alpha/métabolisme , Facteur de nécrose tumorale alpha/analyse , Cholécystite/anatomopathologie , Cholécystite/métabolisme , Substance P/métabolisme , Vésicule biliaire/anatomopathologie , Vésicule biliaire/métabolisme , Récepteurs à l'interleukine-2/métabolisme , Sujet âgé , Maladie chronique , Marqueurs biologiques/métabolisme , Marqueurs biologiques/analyse , Cholécystite aigüe/anatomopathologie , Cholécystite aigüe/métabolisme , Cholécystite aigüe/chirurgieRÉSUMÉ
Some observational studies have highlighted a significant association between cholecystitis and factors leading to sudden death; however, the specific relationship between the 2 has not been fully elucidated. The primary objective of this study was to elucidate the causal interplay between cholecystitis and augmented risk of sudden cardiac death. We used large-scale genetic summary data from genome-wide association study, genetic summary statistics were sourced from 3 eminent repositories: the UK Biobank (Nâ =â 463,010), the FinnGen consortium (Nâ =â 215,027), and the European Bioinformatics Institute (Nâ =â 471,251). By employing 2-sample Mendelian randomization (MR) to decipher the causal interplay between cholecystitis and sudden death etiologies, a meta-analytical approach was employed to amalgamate the findings derived from these disparate data sources. The primary MR methodologies used included inverse variance weighting with random effects, inverse variance weighting with fixed effects, maximum likelihood, MR-Egger, and weighted median. Subsequently, we performed heterogeneity testing, polyvalency examination, and sensitivity analysis to bolster the robustness of causal relationship assessments. Meta-analysis and amalgamating variegated data sources revealed a statistically significant inverse correlation between cholecystitis and ventricular arrhythmias (odds ratio, 0.896; 95% confidence interval: 0.826-0.971; Pâ =â .008). Similarly, an inverse association was observed between cholecystitis and aortic aneurysm (odds ratio, 0.899; 95% confidence interval: 0.851-0.951, Pâ <â .001). This study substantiates the absence of a direct causal link between cholecystitis and cerebrovascular accidents (Pâ =â .771), pulmonary embolism (Pâ =â .071), and acute myocardial infarction (Pâ =â .388). A direct causal correlation existed between cholecystitis and sudden death associated with ventricular arrhythmias and aortic aneurysms. The onset of cholecystitis may mitigate the risk of sudden death due to ventricular arrhythmias and aortic aneurysms.
Sujet(s)
Cholécystite , Mort subite cardiaque , Étude d'association pangénomique , Analyse de randomisation mendélienne , Humains , Mort subite cardiaque/épidémiologie , Mort subite cardiaque/étiologie , Cholécystite/génétique , Facteurs de risqueSujet(s)
Cholécystite , Vésicule biliaire , Humains , Cholécystite/chirurgie , Vésicule biliaire/traumatismes , Vésicule biliaire/chirurgie , Vésicule biliaire/imagerie diagnostique , Maladies de la vésicule biliaire/chirurgie , Maladies de la vésicule biliaire/imagerie diagnostique , Rupture spontanée/chirurgieRÉSUMÉ
OBJECTIVE: To investigate risks of multiple adverse outcomes associated with use of antipsychotics in people with dementia. DESIGN: Population based matched cohort study. SETTING: Linked primary care, hospital and mortality data from Clinical Practice Research Datalink (CPRD), England. POPULATION: Adults (≥50 years) with a diagnosis of dementia between 1 January 1998 and 31 May 2018 (n=173 910, 63.0% women). Each new antipsychotic user (n=35 339, 62.5% women) was matched with up to 15 non-users using incidence density sampling. MAIN OUTCOME MEASURES: The main outcomes were stroke, venous thromboembolism, myocardial infarction, heart failure, ventricular arrhythmia, fracture, pneumonia, and acute kidney injury, stratified by periods of antipsychotic use, with absolute risks calculated using cumulative incidence in antipsychotic users versus matched comparators. An unrelated (negative control) outcome of appendicitis and cholecystitis combined was also investigated to detect potential unmeasured confounding. RESULTS: Compared with non-use, any antipsychotic use was associated with increased risks of all outcomes, except ventricular arrhythmia. Current use (90 days after a prescription) was associated with elevated risks of pneumonia (hazard ratio 2.19, 95% confidence interval (CI) 2.10 to 2.28), acute kidney injury (1.72, 1.61 to 1.84), venous thromboembolism (1.62, 1.46 to 1.80), stroke (1.61, 1.52 to 1.71), fracture (1.43, 1.35 to 1.52), myocardial infarction (1.28, 1.15 to 1.42), and heart failure (1.27, 1.18 to 1.37). No increased risks were observed for the negative control outcome (appendicitis and cholecystitis). In the 90 days after drug initiation, the cumulative incidence of pneumonia among antipsychotic users was 4.48% (4.26% to 4.71%) versus 1.49% (1.45% to 1.53%) in the matched cohort of non-users (difference 2.99%, 95% CI 2.77% to 3.22%). CONCLUSIONS: Antipsychotic use compared with non-use in adults with dementia was associated with increased risks of stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia, and acute kidney injury, but not ventricular arrhythmia. The range of adverse outcomes was wider than previously highlighted in regulatory alerts, with the highest risks soon after initiation of treatment.
Sujet(s)
Atteinte rénale aigüe , Neuroleptiques , Appendicite , Cholécystite , Démence , Défaillance cardiaque , Infarctus du myocarde , Pneumopathie infectieuse , Accident vasculaire cérébral , Thromboembolisme veineux , Adulte , Humains , Femelle , Mâle , Neuroleptiques/usage thérapeutique , Études de cohortes , Thromboembolisme veineux/épidémiologie , Appendicite/complications , Accident vasculaire cérébral/épidémiologie , Infarctus du myocarde/épidémiologie , Troubles du rythme cardiaque/complications , Défaillance cardiaque/induit chimiquement , Démence/traitement médicamenteux , Pneumopathie infectieuse/traitement médicamenteux , Atteinte rénale aigüe/induit chimiquementSujet(s)
Cholécystite , Hidrosadénite suppurée , Pancréatite , Humains , Hidrosadénite suppurée/complications , Hidrosadénite suppurée/épidémiologie , Études rétrospectives , Mâle , Femelle , Adulte , Cholécystite/épidémiologie , Cholécystite/étiologie , Cholécystite/complications , Pancréatite/épidémiologie , Pancréatite/étiologie , Adulte d'âge moyen , Facteurs de risque , Jeune adulteRÉSUMÉ
Kaempferol (KPR), a flavonoid compound found in various plants and foods, has garnered attention for its anti-inflammatory, antioxidant, and anticancer properties. In preliminary studies, KPR can modulate several signaling pathways involved in inflammation, making it a candidate for treating cholecystitis. This study aimed to explore the effects and mechanisms of KPR on lipopolysaccharide (LPS)-induced human gallbladder epithelial cells (HGBECs). To assess the impact of KPR on HGBECs, the HGBECs were divided into control, KPR, LPS, LPS + KPR, and LPS + UDCA groups. Cell viability and cytotoxicity were evaluated by MTT assay and lactate dehydrogenase (LDH) assay, respectively, and concentrations of KPR (10-200 µM) were tested. LPS-induced inflammatory responses in HGBECs were to create an in vitro model of cholecystitis. The key inflammatory markers (IL-1ß, IL-6, and TNF-α) levels were quantified using ELISA, The modulation of the MAPK/NF-κB signaling pathway was measured by western blot using specific antibodies against pathway components (p-IκBα, IκBα, p-p65, p65, p-JNK, JNK, p-ERK, ERK, p-p38, and p38). The cell viability and LDH levels in HGBECs were not significantly affected by 50 µM KPR, thus it was selected as the optimal KPR intervention concentration. KPR increased the viability of LPS-induced HGBECs. Additionally, KPR inhibited the inflammatory factors level (IL-1ß, IL-6, and TNF-α) and protein expression (iNOS and COX-2) in LPS-induced HGBECs. Furthermore, KPR reversed LPS-induced elevation of p-IκBα/IκBα, p-p65/p65, p-JNK/JNK, p-ERK/ERK, and p-p38/p38 ratios. KPR attenuates the LPS-induced inflammatory response in HGBECs, possibly by inhibiting MAPK/NF-κB signaling.
Sujet(s)
Cholécystite , Facteur de transcription NF-kappa B , Humains , Facteur de transcription NF-kappa B/métabolisme , Lipopolysaccharides/toxicité , Inhibiteur alpha de NF-KappaB/métabolisme , Facteur de nécrose tumorale alpha/métabolisme , Interleukine-6/métabolisme , Kaempférols/pharmacologie , Transduction du signal , Inflammation/induit chimiquement , Inflammation/traitement médicamenteux , Cellules épithéliales/métabolisme , Système de signalisation des MAP kinasesRÉSUMÉ
BACKGROUND: This study aimed to investigate the differences in the microbiota composition of serum exosomes from patients with acute and chronic cholecystitis. METHOD: Exosomes were isolated from the serum of cholecystitis patients through centrifugation and identified and characterized using transmission electron microscopy and nano-flow cytometry. Microbiota analysis was performed using 16S rRNA sequencing. RESULTS: Compared to patients with chronic cholecystitis, those with acute cholecystitis exhibited lower richness and diversity. Beta diversity analysis revealed significant differences in the microbiota composition between patients with acute and chronic cholecystitis. The relative abundance of Proteobacteria was significantly higher in exosomes from patients with acute cholecystitis, whereas Actinobacteria, Bacteroidetes, and Firmicutes were significantly more abundant in exosomes from patients with chronic cholecystitis. Furthermore, functional predictions of microbial communities using Tax4Fun analysis revealed significant differences in metabolic pathways such as amino acid metabolism, carbohydrate metabolism, and membrane transport between the two patient groups. CONCLUSIONS: This study confirmed the differences in the microbiota composition within serum exosomes of patients with acute and chronic cholecystitis. Serum exosomes could serve as diagnostic indicators for distinguishing acute and chronic cholecystitis.
Sujet(s)
Cholécystite aigüe , Cholécystite , Exosomes , Microbiome gastro-intestinal , Microbiote , Humains , ARN ribosomique 16S/génétique , Microbiome gastro-intestinal/génétique , Fèces/microbiologie , Microbiote/génétiqueRÉSUMÉ
This case report presents a primigravida in her 20s with a history of seizure disorder and chronic cholecystitis, who presented at 30 weeks and 6 days of gestation with upper abdominal pain, fever and vomiting. Initially diagnosed with acute calculous cholecystitis, the patient's condition rapidly deteriorated, resulting in fetal demise and the development of severe complications. Subsequent investigations revealed an enlarged fatty liver and signs of acute liver failure. The diagnosis of acute fatty liver of pregnancy was initially considered but later ruled out, and the patient was diagnosed with hepatitis E based on positive anti-hepatitis E virus IgM antibodies. Prompt termination of pregnancy was performed, followed by intensive care management. After a prolonged hospital stay, the patient recovered and was discharged in stable condition. This case emphasises the importance of considering hepatitis E as a potential cause of acute liver failure in pregnant women and the need for early recognition and multidisciplinary management to achieve favourable outcomes.
Sujet(s)
Cholécystite , Stéatose hépatique , Hépatite E , Défaillance hépatique aigüe , Complications de la grossesse , Femelle , Humains , Grossesse , Cholécystite/complications , Stéatose hépatique/complications , Hépatite E/complications , Hépatite E/diagnostic , Défaillance hépatique aigüe/complications , AdulteRÉSUMÉ
Acute acalculous cholecystitis (AAC) represents cholecystitis without gallstones, occurring in approximately 5-10% of all cases of acute cholecystitis in adults. Several risk factors have been recognized, while infectious diseases can be a cause of cholecystitis in otherwise healthy people. Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has spread worldwide, leading to an unprecedented pandemic. The virus enters cells through the binding of the spike protein to angiotensin-converting enzyme 2 (ACE2) receptors expressed in many human tissues, including the epithelial cells of the gastrointestinal (GI) tract, and this explains the symptoms emanating from the digestive system. Acute cholecystitis has been reported in patients with COVID-19. The purpose of this review is to provide a detailed analysis of the current literature on the pathogenesis, diagnosis, management, and outcomes of AAC in patients with COVID-19.
Sujet(s)
Cholécystite alithiasique , COVID-19 , Cholécystite aigüe , Cholécystite , Adulte , Humains , SARS-CoV-2/métabolisme , Cholécystite alithiasique/diagnostic , Peptidyl-Dipeptidase A/métabolismeRÉSUMÉ
BACKGROUND AND AIMS: Cholecystitis can occur after self-expandable metallic stent (SEMS) placement for malignant biliary obstruction (MBO), but the best treatment option for cholecystitis has not been determined. Here, we aimed to identify the risk factors of cholecystitis after SEMS placement and determine the best treatment option. METHODS: Incidence, treatments, and predictive factors of cholecystitis were retrospectively evaluated in 1084 patients with distal MBO (DMBO) and 353 patients with hilar MBO (HMBO) who underwent SEMS placement at 12 institutions from January 2012 to March 2021. RESULTS: Cholecystitis occurred in 7.5% of patients with DMBO and 5.9% of patients with HMBO. The recurrence rate was significantly lower (P = .043) and the recurrence-free period significantly longer (P = .039) in endoscopic procedures than in percutaneous procedures for cholecystitis treatment. EUS-guided gallbladder drainage (EUS-GBD) was better in terms of technical success, procedure time, and recurrence-free period than endoscopic transpapillary gallbladder drainage. Obstruction across the cystic duct orifice by tumor (P = .015) and by stent (P = .037) were independent risk factors for cholecystitis in DMBO. Cases with multiple SEMS placements (odds ratio [OR], 11; 95% confidence interval [CI], 0.68-190; P = .091) and with gallbladder stones (OR, 2.3; 95% CI ,0.92-5.6; P = .075) had a higher risk for cholecystitis in HMBO. CONCLUSIONS: The incidences of cholecystitis after SEMS placement for DMBO and HMBO were similar. EUS-GBD is the optimal treatment option for patients with cholecystitis after SEMS placement for MBO.
Sujet(s)
Cholécystite , Cholestase , Drainage , Endoprothèses métalliques auto-expansibles , Humains , Études rétrospectives , Mâle , Femelle , Cholécystite/étiologie , Sujet âgé , Endoprothèses métalliques auto-expansibles/effets indésirables , Facteurs de risque , Adulte d'âge moyen , Drainage/méthodes , Cholestase/étiologie , Cholestase/chirurgie , Cholestase/thérapie , Sujet âgé de 80 ans ou plus , Endosonographie , Tumeurs du pancréas/complications , Tumeurs des canaux biliaires/complications , Incidence , Complications postopératoires/étiologie , Complications postopératoires/épidémiologie , RécidiveRÉSUMÉ
INTRODUCTION: A textbook outcome patient is one in which the operative course passes uneventful, without complications, readmission or mortality. There is a lack of publications in terms of TO on acute cholecystitis. OBJETIVE: The objective of this study is to analyze the achievement of TO in patients with urgent early cholecystectomy (UEC) for Acute Cholecystitis. and to identify which factors are related to achieving TO. MATERIALS AND METHODS: This is a post hoc study of the SPRiMACC study. It´s a prospective multicenter observational study run by WSES. The criteria to define TO in urgent early cholecystectomy (TOUEC) were no 30-day mortality, no 30-day postoperative complications, no readmission within 30 days, and hospital stay ≤ 7 days (75th percentile), and full laparoscopic surgery. Patients who met all these conditions were taken as presenting a TOUEC. OUTCOMES: 1246 urgent early cholecystectomies for ACC were included. In all, 789 patients (63.3%) achieved all TOUEC parameters, while 457 (36.6%) failed to achieve one or more parameters and were considered non-TOUEC. The patients who achieved TOUEC were younger had significantly lower scores on all the risk scales analyzed. In the serological tests, TOUEC patients had lower values for in a lot of variables than non-TOUEC patients. The TOUEC group had lower rates of complicated cholecystitis. Considering operative time, a shorter duration was also associated with a higher probability of reaching TOUEC. CONCLUSION: Knowledge of the factors that influence the TOUEC can allow us to improve our results in terms of textbook outcome.